Article metrics

Download PDFPDF

Patient-reported outcomes in the RELIGHT clinical trial of ranibizumab in diabetic macular oedema

 

Online download statistics by month:

Online download statistics by month: April 2019 to March 2024

AbstractFullPdf
Apr 201919197
May 201931731444
Jun 201923423138
Jul 201910010018
Aug 2019555117
Sep 2019313014
Oct 2019302813
Nov 2019363512
Dec 2019353425
Jan 2020433811
Feb 202040406
Mar 202032298
Apr 202027276
May 202023233
Jun 202022234
Jul 2020828210
Aug 202022223
Sep 202029247
Oct 2020303010
Nov 202020207
Dec 202023237
Jan 2021403610
Feb 202112123
Mar 202121218
Apr 202113133
May 2021232110
Jun 202122222
Jul 202119194
Aug 202118173
Sep 202116176
Oct 2021252518
Nov 2021232317
Dec 202124242
Jan 202219207
Feb 202215153
Mar 202221206
Apr 202228266
May 202240409
Jun 202226265
Jul 2022182110
Aug 202242429
Sep 202227274
Oct 2022414112
Nov 202217176
Dec 202211111
Jan 202318163
Feb 202340428
Mar 202311124
Apr 202310103
May 202315159
Jun 202311102
Jul 202313136
Aug 2023151510
Sep 202310104
Oct 202315163
Nov 202318182
Dec 202314145
Jan 202421219
Feb 202410103
Mar 2024222313
Total20542024518